Patent · US Active

Anti-MDL-1 antibodies

US8153134B2 · kind B2 · utility

6Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 21, 2008
Grant dateApr 10, 2012
Priority date—
Expiry dateAug 5, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies to human MDL-1 are provided, as well as uses thereof, e.g., in treatment of immune disorders, in particular, infectious diseases and sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.